• MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

ACTRIMS Forum 2022: News Network

Key opinion leaders and presenters at the ACTRIMS Forum 2022 share their perspectives on the latest data and updates in the management of patients with multiple sclerosis (MS).

EP. 1: Major Themes, Focuses at ACTRIMS 2022

February 11th 2022

Jeffrey Cohen, MD, director, Mellen Center for MS Treatment and Research, Cleveland Clinic; and president, ACTRIMS, discussed what he is looking forward to at the 2022 ACTRIMS Forum, as well as the overarching themes of the meeting. [WATCH TIME: 2 minutes]

EP. 2: Transcranial Direct Current Stimulation in an At-Home Setting

March 8th 2022

Leigh Charvet, PhD, professor of neurology, NYU Grossman School of Medicine, discussed the potential feasibility of at-home tDCS for patients with multiple sclerosis to boost cognitive training. [WATCH TIME: 2 minutes]

EP. 3: Role of Antigen Reactive T Cells in Multiple Sclerosis

March 9th 2022

The William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology, and Neurologist-in-Chief at Yale-New Haven Hospital spoke to the findings of a recent assessment of T cells in multiple sclerosis. [WATCH TIME: 4 minutes]

EP. 4: Improved Recognition of Autoimmune Encephalitis

March 10th 2022

The staff neurologist at Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research offered her insight into improving the recognition of autoimmune encephalitis. [WATCH TIME: 2 minutes]

EP. 5: Chronic Active Lesion Evolution in Multiple Sclerosis

March 11th 2022

The assistant professor of neurology at the University of Pennsylvania discussed how 7T MRI features of newly developed MS lesions can predict the development of chronic active lesions. [WATCH TIME: 3 minutes]